8-K: IDEX Reports Record Q4, Full Year 2025; AI Drives Orders

IDEX Corporation announced record fourth quarter and full year 2025 financial results, driven by strong order growth in its Health & Science Technologies segment, particularly from AI-related projects.

Summary

• Fourth quarter 2025 sales reached a record $899 million, increasing 4% on a reported basis and 1% organically compared to the fourth quarter of 2024.
• Reported diluted EPS for Q4 2025 was $1.71, up 6%, while adjusted diluted EPS increased 3% to $2.10.
• Record orders of $979 million in Q4 2025 surged 20% on a reported basis and 16% organically, primarily fueled by strength in the Health & Science Technologies (HST) segment.
• Full year 2025 sales hit a record $3.5 billion, up 6% reported and 1% organically over 2024.
• Full year 2025 reported diluted EPS decreased 3% to $6.41, but adjusted diluted EPS increased 1% to $7.95.
• Operating cash flow for the full year was $680 million, a 2% increase, representing 141% of net income.
• Free cash flow for the full year was $617 million, up 2%, with a conversion rate of 103%.
• IDEX utilized $73 million for share repurchases in the fourth quarter and $248 million for the full year.
• The HST segment's net sales grew 9% (5% organic) in Q4, benefiting from increases in data center, semiconductor consumables, and space and defense businesses.
• The Fluid & Metering Technologies (FMT) segment saw net sales increase 2% (1% organic) in Q4, driven by municipal water businesses, partially offset by declines in semiconductor, chemical, energy, and industrial sectors.
• The Fire & Safety/Diversified Products (FSDP) segment experienced a 3% decrease in net sales (5% organic) in Q4, due to lower volumes in Fire and Safety and Dispensing businesses.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, particularly given the challenging demand environment in some segments. The significant order growth driven by AI-related projects in HST and robust cash flow generation are key positives, positioning the company well for future growth despite some headwinds.

Positives

• Achieved record sales of $899 million for Q4 2025 and $3.5 billion for the full year 2025.
• Recorded record orders of $979 million in Q4 2025, demonstrating significant reported growth of 20% and organic growth of 16%, largely driven by the HST segment.
• The HST segment showed strong organic sales growth of 5% in Q4, positively impacted by increasing demand for AI-related projects, including data center power solutions and semiconductor applications.
• Full year operating cash flow increased 2% to $680 million, representing a robust 141% of net income.
• Full year free cash flow increased 2% to $617 million, with a strong conversion rate of 103%.
• Adjusted diluted EPS for the full year increased by 1% to $7.95, indicating underlying operational improvements.
• Operational productivity improvements, platform optimization savings, and cost containment actions contributed to gross margin increases.
• The company utilized $248 million for share repurchases during the full year 2025.

Negatives

• Full year 2025 reported diluted EPS decreased 3% to $6.41, primarily due to higher depreciation, amortization, restructuring costs, interest expense, and taxes.
• The effective tax rate increased in 2025 due to new legislation that lowered tax benefits from certain foreign-sourced income, increased state income taxes, and a less favorable mix of earnings in higher tax rate jurisdictions.
• Lower volumes in the Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP) segments partially offset overall sales growth.
• The FSDP segment experienced a 5% organic sales decrease in Q4 2025, driven by lower volumes in its Fire and Safety and Dispensing businesses.
• Adjusted EBITDA margin for the FMT segment decreased by 20 basis points in Q4 2025, primarily due to volume deleverage and unfavorable mix.

Risks

• Levels of industrial activity and economic conditions in the U.S. and other countries, including uncertainties in the financial markets.
• Pricing pressures, including inflation and rising interest rates, and other competitive factors and levels of capital spending in certain industries.
• The impact of severe weather events, natural disasters, and public health threats.
• Economic and political consequences resulting from terrorist attacks, wars, and global conflicts.
• The company's ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis.
• Cybersecurity incidents.
• The continued growth of artificial intelligence (AI) and any related changes to demand in AI-driven markets served by the company's customers.
• The relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness.
• Political and economic conditions in countries in which the company operates.
• Developments with respect to trade policy and existing, new or increased tariffs or other similar measures.
• Changes to applicable laws and regulations, including tax laws.
• Interest rates.
• Capacity utilization and the effect this has on costs.
• Labor markets.
• Supply chain conditions and material costs.
• Risks related to environmental, social, and corporate governance issues, including those related to climate change and sustainability.
• Developments with respect to contingencies, such as litigation and environmental matters.

Future Outlook

For the full year 2026, IDEX projects organic sales to increase 1% to 2% over the prior year and adjusted diluted EPS to be between $8.15 and $8.35. For the first quarter of 2026, organic sales are projected to increase approximately 1% from the prior year period, with adjusted diluted EPS expected to be $1.73 to $1.78.

Management Comments

• "Our teams around the world executed well to close out 2025, and I was encouraged to see our platform growth strategies deliver visible results." Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President.
• "Order growth in our HST segment built momentum in the fourth quarter from increasing demand for AI-related projects, including data center power solutions and semiconductor applications." Eric D. Ashleman.
• "Businesses in our FMT and FSDP segments are aggressively managing all the factors in their control in a challenging demand environment." Eric D. Ashleman.
• "We remain committed to executing our strategy of building focused growth platforms that leverage differentiated capabilities to solve our customers most complex problems." Eric D. Ashleman.
• "We focus investment choices and resource allocation across every aspect of our business using an 8020 mindset to drive platform growth and margin expansion." Eric D. Ashleman.
• "I am extremely proud of how our teams are executing across our portfolio of market-leading businesses and am confident that we are set up to deliver strong performance across the cycle." Eric D. Ashleman.

Industry Context

StockSavvy.ai notes that IDEX's strong order growth in its Health & Science Technologies (HST) segment, particularly from AI-related projects like data center power solutions and semiconductor applications, aligns with broader industry trends of increasing investment and demand in the artificial intelligence and advanced technology sectors. While some segments face challenging demand environments, the company's strategic focus on differentiated capabilities positions it to capitalize on high-growth areas.

Stakeholder Impact

• Shareholders: Benefit from record sales and orders, increased adjusted EPS, strong cash flow, and share repurchases, indicating a healthy return on investment and potential for future growth.
• Employees: Benefit from operational productivity improvements and platform optimization savings, though some restructuring actions and organizational changes occurred in 2025.
• Customers: Benefit from IDEX's commitment to solving complex problems with differentiated capabilities, particularly in high-demand and critical industries.

Next Steps

• IDEX will host its fourth quarter earnings conference call on Wednesday, February 4, 2026, at 8:00 a.m. CT.
• Associated earnings presentation materials will be available on the Company's website prior to the call.
• A replay of the earnings call and associated earnings presentation materials will be available on the Company's website after the call.

Key Dates

Recommendation

The filing indicates robust underlying business health with record sales and orders, particularly driven by strategic alignment with high-growth sectors like AI. Despite some macroeconomic headwinds impacting certain segments and a higher tax rate, the company's strong cash flow generation, share repurchase program, and positive 2026 outlook for organic sales and adjusted EPS suggest a compelling investment opportunity. The management's focus on platform growth and margin expansion, coupled with strong execution, positions IDEX for continued outperformance.

Keywords

IDEX Corporation, IEX, Financial Results, Q4 2025, Full Year 2025, Earnings, Revenue, EPS, Orders, Organic Sales, Health & Science Technologies, Fluid & Metering Technologies, Fire & Safety/Diversified Products, AI-related projects, Data Center Power Solutions, Semiconductor Applications, Cash Flow, Share Repurchases, 2026 Outlook, Industrial Products, Engineered Products